Health Provider Login
Patient Login
For most health systems, patient financing is positioned as a back-end solution—a way to help patients manage balances after care is delivered. But the structure of that financing model—recourse vs. nonrecourse—isn’t just a financial decision.
It determines:
- How many patients actually get access to payment solutions
- How much revenue you ultimately collect
- And who controls the patient financial experience
In short, it determines whether your financing strategy is driving performance—or quietly limiting it.
The Core Difference Isn’t Financing. It’s Control.
At a high level, the distinction is simple:
- Recourse models keep responsibility within the health system
- Nonrecourse models transfer that responsibility to a third-party lender
Nonrecourse is often positioned as “safer” because it removes bad debt risk. But in practice, that risk doesn’t disappear—it gets repriced. And that’s where the tradeoff begins.
What Nonrecourse Really Costs You
To protect themselves, nonrecourse lenders must manage risk aggressively. That typically means:
- Credit checks and approval thresholds
- Higher fees or interest structures
- More rigid repayment requirements
The result? A portion of your patient population—often the very patients who need support the most—never qualify. That’s not just a patient access issue. It’s a revenue issue.
Every declined patient is a balance that’s far less likely to be collected.
Recourse: A Different Approach to Growth
Recourse models take a fundamentally different approach. Instead of filtering patients out, they are designed to bring more patients into the system—removing credit barriers and enabling flexible, 0% interest payment pathways.
The impact is straightforward:
- Higher patient participation
- More balances converted into payment plans
- Greater long-term cash yield
Yes, recourse means the provider retains some level of default exposure.
But here’s what many organizations discover: When more patients are engaged in structured repayment programs, overall collections increase—and risk becomes far more manageable than expected.
The Overlooked Factor: Patient Experience
There’s another dimension that often gets missed: who owns the patient relationship.
In nonrecourse models, that relationship is often handed off to a third party. Communication, repayment terms, and financial interactions are no longer fully under your control.
In recourse models, you retain that control.
That means:
- A more consistent, patient-friendly experience
- Alignment with your brand and mission
- Greater flexibility in how financial support is delivered
In a market where patient experience is directly tied to loyalty, reputation, and long-term value, this matters more than ever.
What High-Performing Systems Are Doing Differently
Leading health systems are shifting how they evaluate financing altogether.
They’re not asking: “Who takes the risk?”
They’re asking: “How much cash do we actually collect—and how many patients do we help in the process?”
That shift changes everything.
Because when you evaluate financing based on:
- Net cash yield
- Patient participation
- Experience and satisfaction
The model that expands access—and keeps patients engaged—almost always outperforms the one that filters them out.
The Bottom Line
You shouldn’t have to choose between financial performance and patient experience. But the structure of your financing model determines whether that tradeoff exists. Recourse models are built to maximize both—by expanding access, maintaining control, and turning more patient balances into real, collected revenue.
And in today’s environment, that’s not just a financing strategy. It’s a growth strategy.